Quick answer
Prescription medications often cost significantly less in Canada than at U.S. retail pharmacy counters for three structural reasons: national ceiling price review for patented brand drugs through Canada's Patented Medicine Prices Review Board (PMPRB), earlier Canadian patent expiration and generic entry for blockbuster drugs like Eliquis, Xarelto, Jardiance, and Farxiga, and the absence of U.S. pharmacy benefit manager (PBM) rebate inflation on cash list prices.12 When comparing your out-of-pocket cost, always match the exact active ingredient, strength, and 90-day supply quantity in our Savings Calculator.
Side-by-side comparison: Canadian vs. U.S. prescription drug pricing
| Pricing Factor | Canadian Pharmacy Market | U.S. Retail Pharmacy Market |
|---|---|---|
| Patented brand list prices | Reviewed by the federal PMPRB against an international basket of reference countries to prevent excessive factory-gate prices1 | Manufacturers set initial Wholesale Acquisition Cost (WAC) freely and raise list prices annually |
| Generic patent-cliff timing | Earlier generic entry for key maintenance drugs such as Apixaban, Rivaroxaban, Empagliflozin, and Dapagliflozin2 | Secondary formulation patents and litigation settlements often delay U.S. retail generic launches by several years |
| Generic price tiering | Pan-Canadian Pharmaceutical Alliance (pCPA) sets transparent, deeply discounted generic price tiers across provinces | Cash-paying patients without a discount card are frequently billed inflated U.S. usual-and-customary retail prices |
| PBM rebate middleman markups | Direct, transparent wholesale and dispensing margins without gross-to-net rebate inflation | High list prices are inflated to fund confidential PBM rebates, penalizing uninsured and high-deductible cash buyers |
1. How Canada's PMPRB and provincial negotiations cap brand prices
In the United States, pharmaceutical manufacturers set their own launch price and can increase the list price once or twice a year, meaning a brand-name inhaler or GLP-1 pen that launched a decade ago may now cost two to three times its original U.S. price.
In Canada, the Patented Medicine Prices Review Board (PMPRB) is an independent federal quasi-judicial body established under the Patent Act.1 The PMPRB monitors the ex-factory prices that patent holders charge for patented medicines sold in Canada, benchmarking them against comparator countries (PMPRB11) and limiting annual price increases so they do not exceed consumer inflation (CPI). While the PMPRB does not set individual pharmacy retail fees, capping the manufacturer's ceiling price at the top of the supply chain keeps Canadian pharmacy acquisition costs for brand-name drugs like Ozempic, Trelegy Ellipta, Eliquis, and Xarelto substantially lower than U.S. wholesale list prices.
2. Earlier generic entry in Canada ("The Patent Cliff Gap")
For many U.S. patients treating atrial fibrillation, blood clots, type 2 diabetes, heart failure, or asthma, the single largest source of savings is earlier Canadian generic availability:2
- Eliquis (Apixaban): While U.S. patents keep retail patients on brand-only Eliquis, Health Canada has approved bioequivalent generic Apixaban in 2.5 mg and 5 mg tablets (see our Generic Eliquis in Canada guide).
- Xarelto (Rivaroxaban): Health Canada has authorized generic Rivaroxaban across 2.5 mg, 10 mg, 15 mg, and 20 mg strengths (see our Generic Xarelto in Canada guide).
- Jardiance (Empagliflozin) and Farxiga (Dapagliflozin): Both SGLT2 inhibitors have Health Canada-approved generic counterparts (Empagliflozin Generic and Dapagliflozin Generic) in our SGLT2 inhibitors directory.
- Symbicort (Budesonide / Formoterol): Canadian pharmacies dispense both brand Symbicort and generic Budesonide/Formoterol (see our Generic Symbicort in Canada guide).
3. Why U.S. cash and high-deductible patients pay the highest prices
In the U.S. pharmacy benefit manager (PBM) system, drugmakers set a high list price and then pay confidential rebates back to PBMs and insurers in exchange for formulary placement. If you are uninsured, in a high-deductible health plan, in a Medicare Part D deductible or coinsurance tier, or taking a medication that your insurer refuses to cover (such as Wegovy or Zepbound for obesity), you are exposed to the unrebated U.S. retail price. Because Canadian cash quotes are based on lower regulated wholesale acquisition costs rather than PBM rebate games, the cash price for a 90-day supply from Canada is often a fraction of the U.S. cash price.
How to compare your true U.S. cost vs. a Canadian cash quote
Before placing an order, make sure you are comparing apples to apples:3
- Match the exact strength and 90-day quantity: Compare 180 tablets of twice-daily Eliquis against 180 tablets, or 3 pens of Lantus against 3 pens in the diabetes directory.
- Compare against your actual U.S. copay: If you have insurance or Medicare Part D that already covers a cheap U.S. generic for $5 to $15, fill it locally. Canadian cash ordering is most valuable when your U.S. copay, coinsurance, or cash price is high (see our Medicare and Canadian prescription costs guide).
- Include shipping in your total: Enter your U.S. price and the Canadian quote into our Savings Calculator and review our price-comparison guide.
Frequently asked questions
Are Canadian prescription drugs cheaper because they are lower quality?
No. Prescription medications dispensed by licensed Canadian pharmacies are regulated by Health Canada under strict Good Manufacturing Practice (GMP) and bioequivalence standards comparable to those of the U.S. FDA. In many cases, brand-name drugs sold in Canada are manufactured in the exact same North American or European facilities as the U.S. version.
Does the Canadian government subsidize medications bought by U.S. residents?
No. Provincial public drug plans in Canada (such as Ontario Drug Benefit or BC PharmaCare) only pay for eligible Canadian residents. When a U.S. patient orders from a licensed Canadian pharmacy, they pay 100% of the private cash price; the price is lower because Canadian wholesale prices and generic tiers are lower, not because Canadian taxpayers subsidize the order.
Why are some generic drugs available in Canada years before the United States?
Pharmaceutical patents are filed and litigated separately in each country. In the United States, manufacturers frequently build "patent thickets" of secondary patents that extend exclusivity into the late 2020s, whereas Canadian patent challenges or expirations often allow Health Canada-approved generics (such as generic Apixaban and Rivaroxaban) to enter the market several years earlier.
Can I use U.S. health insurance or Medicare at a Canadian pharmacy?
No. U.S. commercial insurance plans and Medicare Part D do not directly bill or reimburse pharmacies outside the United States.3 All orders placed through our service are straightforward USD cash transactions.
